✦ LIBER ✦

Structure–activity relationships of tulipalines, tuliposides, and related compounds as inhibitors of MurA

✍ Scribed by Thomas Mendgen; Therese Scholz; Christian D. Klein

Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 603 KB
Volume: 20
Category: Article
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2010.07.139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synthesis and structure-activity relatio

Synthesis and structure-activity relationships of benzophenones as inhibitors of cathepsin D

✍ Celia A. Whitesitt; Richard L. Simon; Jon K. Reel; Sandra K. Sigmund; Michael L. 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 351 KB

ChemInform Abstract: Synthesis of Pirone

ChemInform Abstract: Synthesis of Pironetin and Related Analogues: Studies on Structure—Activity Relationships as Tubulin Assembly Inhibitors.

✍ Hiroyuki Watanabe; Hidenori Watanabe; Takeo Usui; Masuo Kondoh; Hiroyuki Osada; 📂 Article 📅 2000 🏛 John Wiley and Sons ⚖ 31 KB 👁 2 views

Synthesis and Structure—Activity Relatio

Synthesis and Structure—Activity Relationships of 1,5-Diazaanthraquinones as Antitumor Compounds.

✍ Carmen Avendano; Jose Maria Perez; M. del Mar Blanco; Jesus Angel de la Fuente; 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 21 KB 👁 2 views

Synthesis and structure-activity relatio

Synthesis and structure-activity relationships of new ACAT inhibitors

✍ JY Nioche; J Decerprit; D Festal 📂 Article 📅 1995 🏛 Elsevier Science 🌐 French ⚖ 732 KB

Structure—Activity Relationships of Nove

Structure—Activity Relationships of Novel Potent MurF Inhibitors.

✍ Yu Gui Gu; et al. et al. 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 76 KB 👁 2 views

Inhibitors of vitamin D hydroxylases: St

Inhibitors of vitamin D hydroxylases: Structure–activity relationships

✍ Inge Schuster; Helmut Egger; Peter Nussbaumer; Romano T. Kroemer 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

## Abstract Aiming at new drugs to efficiently treat diseases, in which either increased or decreased levels of active vitamin D are desirable, we have designed some 400 structurally different azole‐type inhibitors and examined their capacity to selectively block vitamin D metabolism by CYP24 or sy